The efficacy of homoeopathic potassium phosphate for mental fatigue
| ISRCTN | ISRCTN16521161 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN16521161 |
| Protocol serial number | N/A |
| Sponsor | University of York (UK) |
| Funder | Department of Health (UK) - National Coordinating Centre for Research Capacity Development, Post-Doctoral Fellowship in Complementary Medicine |
- Submission date
- 25/06/2009
- Registration date
- 01/09/2009
- Last edited
- 23/05/2013
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Michael Emmans Dean
Scientific
Scientific
Department of Health Sciences
University of York
Seebohm Rowntree Building
University Road
York
YO10 5DD
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised placebo-controlled cross-over trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | A randomised placebo-controlled trial of homoeopathic potassium phosphate 6x for mental fatigue |
| Study objectives | That a homeopathic specific used in the treatment of attentional problems will improve performance on an attention test. |
| Ethics approval(s) | Health Services Research Governance Committee (HSRGC) of the University of York approved on the 13th March 2007. As this trial did not involve any patients, it did not have to go through the National Health Service ethics system. |
| Health condition(s) or problem(s) studied | Mental fatigue |
| Intervention | Intervention: a single homeopathic dose of 0.6 g lactose powder, medicated with Kali-phos 6x (in 90% ethanol/water solution) Control: identical placebo consisting of 0.6 g lactose powder, treated with unmedicated 90% ethanol/water solution Treatment consisted of a single dose, crossed over at the same time on the same day one week later. There was no follow-up. |
| Intervention type | Drug |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Potassium phosphate |
| Primary outcome measure(s) |
Accuracy on the Stroop-colour-word test of executive function, measured 10 minutes after medication (at the same time on the same day one week apart). |
| Key secondary outcome measure(s) |
No secondary outcome measures |
| Completion date | 01/09/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 86 |
| Key inclusion criteria | 1. Healthy staff and student volunteers, aged 19 to 62 years, either sex 2. Recruited from within the University of York 3. Reporting fatigue from mental work |
| Key exclusion criteria | 1. Current use of homeopathy for any condition 2. Current prescribed stimulant medication 3. Use of self-prescribed stimulants (e.g. caffeine-based products) during the study 4. Chronic fatigue 5. Unable to communicate in English |
| Date of first enrolment | 01/06/2007 |
| Date of final enrolment | 01/09/2007 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Department of Health Sciences
York
YO10 5DD
United Kingdom
YO10 5DD
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/10/2012 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |